Skip to evidence report

ASPC.adipocyte_capillary_interface: Studies — page 11

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,040 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 10,001–11,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for ASPC.adipocyte_capillary_interface
#Trait / studyIndividual trait IDMean IC score
10001KLRF1 levelsGCST904697120.03
10002aparc-DKTatlas rh thickness lingualGCST900035820.03
10003LRIG3 levelsGCST904697950.03
10004Multi-site chronic pain | Other traitUKBB000004900.03
10005IDP dMRI ProbtrackX OD slf rGCST900044720.03
10006PDGFA/SNAP23 ratioGCST903156190.03
10007Principal component-derived dietary pattern 1GCST901330060.03
10008F-cooking flavour liking (derived food-liking factor)GCST900947420.03
10009SpermatoceleFING000013190.03
10010Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T178ECGA0001780.03
10011Chronic obstructive pulmonary disease in never smokersGCST900165890.03
10012F-sharp flavour liking (derived food-liking factor)GCST900948370.03
10013SCGB3A1 levelsGCST904705420.03
10014EDAR/SNAP23 ratioGCST903145870.03
10015Alcohol-induced chronic pancreatitisFING000000550.03
10016AsthmaGCST900143250.03
10017ARHGAP25/RNF41 ratioGCST903133450.03
10018Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T281ECGA0002810.03
10019Milk chocolate likingGCST900948010.03
10020Weight (maximum, inv-normal transformed)GCST904764600.03
10021Lymphoid neoplasmsGCST906247430.03
10022SIGLEC8 levelsGCST900898860.03
10023CDCP1/IL18BP ratioGCST903139370.03
10024Illnesses of father - None of the above (group 2) | Family historyUKBB000003460.03
10025GALNT10/TNFSF12 ratioGCST903149160.03
10026Diseases of sebaceous glands (PheCode 706)GCST904762100.03
10027Osteopathies and chondropathiesFING000009130.03
10028CAG-269 sp001915995 abundance in stoolGCST900322660.03
10029MAP2 levelsGCST904698530.03
10030KIFBP/TACC3 ratioGCST903152490.03
10031Sensitivity / hurt feelings | Mental healthUKBB000007660.03
10032Urine adenosine levels in chronic kidney diseaseGCST902647570.03
10033Free cholesterol levels in IDLGCST900928350.03
10034ICD10 O42: Premature rupture of membranesGCST904542380.03
10035Other serious medical condition/disability diagnosed by doctor | Medical conditionsUKBB000006190.03
10036Remnant cholesterol (non-HDL, non-LDL -cholesterol)GCST900929430.03
10037DCTN1/TRIAP1 ratioGCST903144340.03
10038PRND levelsGCST904703330.03
10039Waist circumference | Body size measuresUKBB000009040.03
10040ICA1/YTHDF3 ratioGCST903151130.03
10041PLXNA4/VASH1 ratioGCST903156910.03
10042Monounsaturated fatty acid levelsGCST905023620.03
10043Type 1 diabetes with ketoacidosis (PheCode 250.11)GCST904756620.03
10044Glucose levels (UKB data field 30740)GCST904680710.03
10045Omega-6 fatty acids levels (UKB data field 23445)GCST902695420.03
10046Ever unenthusiastic/disinterested for a whole week | Mental healthUKBB000002260.03
10047F-vegetarian liking (derived food-liking factor)GCST900948630.03
10048Operative procedures - Injection of therapeutic substance into joint | Summary OperationsUKBB000005820.03
10049Vegetables likingGCST900948620.03
10050CDH2 levelsGCST904686730.03
10051Haemoglobin concentration (UKB data field 30020)GCST904680740.03
10052ICD10 O24.4: Diabetes mellitus arising in pregnancyGCST904542360.03
10053CD209/CLEC4G ratioGCST903137500.03
10054Qualifications - Other professional qualifications eg: nursing, teaching | EducationUKBB000007320.03
10055PHOSPHO1 levelsGCST904702270.03
10056CCL3 levelsGCST900120550.03
10057Triglyceride levels in medium LDLGCST900929140.03
10058Body mass index (BMI, maximum, inv-normal transformed)GCST904751530.03
10059Type 2 diabetes, wide definitionFING000013830.03
10060IRAK4/VASH1 ratioGCST903152010.03
10061Type1 diabetes, definitions combined, early onsetFING000013840.03
10062Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T176ECGA0001760.03
10063Body mass indexGCST900187270.03
10064FUT8/SORT1 ratioGCST903148920.03
10065HEXIM1/NT5C3A ratioGCST903150480.03
10066Left-hemisphere control network to amygdala white-matter structural connectivityGCST903027570.03
10067Current employment status - Retired | EmploymentUKBB000001590.03
10068CTRB1 levelsGCST904689050.03
10069X-24544 levelsGCST902006360.03
10070Parental longevity (mother's attained age)GCST0066960.03
10071DTI autoptx MD ptr r tractGCST903852400.03
10072FADD/PLIN3 ratioGCST903147720.03
10073CASP3/SNAP23 ratioGCST903136440.03
10074Cereal consumption (bowls per week) (UKB data field 1458)GCST901329820.03
10075Other peripheral vertigoFING000010880.03
10076F9/RARRES2 ratioGCST903147490.03
10077Principal component-derived dietary pattern 8GCST901330130.02
10078ALCAM/NOTCH1 ratioGCST903132410.02
10079Blood urea nitrogen (BUN, minimum, inv-norm transformed)GCST904751680.02
10080mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed)GCST904754600.02
10081Pure hypercholesterolaemiaFING000012300.02
10082Nontoxic multinodular goitreFING000008880.02
10083OPTC levelsGCST904701280.02
10084aparc-Desikan rh area precentralGCST900031300.02
10085GZMA levelsGCST902413230.02
10086MMP8/TGFA ratioGCST903154660.02
10087Lysophosphatidylcholine (26:0) [sn2] levelsGCST900241890.02
10088aparc-Desikan lh volume precuneusGCST900027920.02
10089Phenylacetylglutamate levelsGCST902000690.02
10090Triglyceride levels in very large HDLGCST900930140.02
10091Cholesterol levels in medium LDLGCST900929040.02
10092LDL direct, adjusted by medication | Lipid or lipoprotein measurementUKBB000003870.02
10093Linoleic acid levelsGCST905020040.02
10094TREH levelsGCST904709590.02
10095DTI TBSS L2 Genu of corpus callosumGCST903844780.02
10096Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T479ECGA0004790.02
10097Tea consumptionGCST900969260.02
10098CST7 levelsGCST904688970.02
10099Saturated fatty acids levels (UKB data field 23448)GCST902695450.02
10100NMNAT1 levelsGCST904700570.02
10101Omega-3 fatty acids levelsGCST904991390.02
10102FOLR2/HAVCR2 ratioGCST903148650.02
10103Primary biliary cholangitisGCST0031290.02
10104ICAM1/REG1A ratioGCST903151140.02
10105Clonal haematopoiesis of indeterminate potential (DNMT3A mutation)GCST901652710.02
10106Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T244ECGU0002440.02
10107Cholesteryl Esters in LDLGCST904983740.02
10108MLN levelsGCST904699130.02
10109Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T177ECGA0001770.02
10110PDGFB/ST6GAL1 ratioGCST903156300.02
10111PsoriasisGCST904681470.02
10112rfMRI connectivity (ICA100 edge 605)GCST900054580.02
10113Other disorders of the musculoskeletal system and connective tissueFING000010380.02
10114GOLM2/STC1 ratioGCST903149520.02
10115General happiness | Happiness and subjective well-beingUKBB000002800.02
10116Total Phosphatidylethanolamine levelsGCST900252070.02
10117GLO1 levelsGCST904693580.02
10118Principal component-derived dietary pattern 45GCST901330500.02
10119Tobacco use disorder | mental disordersUKBB000008240.02
10120VCAM1 levelsGCST902433170.02
10121Phospholipid levels in small VLDLGCST900929760.02
10122STK11/USP8 ratioGCST903158920.02
10123Administrative and legal statuses - NHS patient: not formally detained | Summary AdministrationUKBB000000120.02
10124APP/BIN2 ratioGCST903133160.02
10125Bipolar disorderGCST0037240.02
10126DTI autoptx L1 fmi tractGCST903851500.02
10127NOTCH1/TIE1 ratioGCST903155460.02
10128Acetone levelsGCST900928050.02
10129Childhood sunburn occasions | Sun exposureUKBB000001300.02
10130PRRT3 levelsGCST904703400.02
10131Word interpolation | Fluid intelligence / reasoningUKBB000009180.02
10132Bicarbonate (minimum, inv-norm transformed)GCST904751500.02
10133ADAM23 levelsGCST902409220.02
10134Number of puzzles correctly solved (baseline)GCST905658400.02
10135Nap during day | SleepUKBB000004920.02
10136Father's age at death | Family historyUKBB000002410.02
10137Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T476ECGA0004760.02
10138Phosphatidylcholine acyl-alkyl C36:4 levelsGCST902400720.02
10139Length of working week for main job | EmploymentUKBB000004050.02
10140Placental weight (paternal genotype, adjusted for sex)GCST902751990.02
10141FADD/NFATC1 ratioGCST903147710.02
10142CTRC levelsGCST904689060.02
10143Polyunsaturated fatty acid levelsGCST905026060.02
10144Other specified diseases of sebaceous glands (PheCode 706.8)GCST904762150.02
10145ANGPT1/MPIG6B ratioGCST903132650.02
10146aparc-Desikan rh thickness lingualGCST900034910.02
10147Number of diet questionnaires completed | Diet questionnaire performanceUKBB000005360.02
10148CD79B/TNFRSF13B ratioGCST903139020.02
10149Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T425ECGU0004250.02
10150aparc-DKTatlas lh volume precuneusGCST900028850.02
10151DTI TBSS L1 Superior longitudinal fasciculus LGCST903844690.02
10152Cholesteryl Esters in Large LDLGCST904979550.02
10153Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T283ECGA0002830.02
10154Chronic obstructive pulmonary disease x ever smoker interaction (main effect)GCST900165860.02
10155CNTN3/NCS1 ratioGCST903141650.02
10156Other noninflammatory disorders of uterus, except cervixFING000010790.02
10157Lysophosphatidylcholine (24:0) [sn2] levelsGCST900241870.02
10158Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T457ECGU0004570.02
10159LHPP levelsGCST904697680.02
10160Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2)GCST904760040.02
10161Mean platelet thrombocyte volume (UKB data field 30100)GCST904680870.02
10162Whiskey likingGCST900948730.02
10163CD300C/LRRC25 ratioGCST903137900.02
10164Disorders of lacrimal systemFING000004410.02
10165Concentration of LDL particlesGCST904984130.02
10166Medication for pain relief, constipation, heartburn - Aspirin | MedicationUKBB000004540.02
10167Venous thromboembolismGCST903997440.02
10168MME/NT5E ratioGCST903154600.02
10169Other non-epithelial cancer of skin (PheCode 172.2)GCST904755800.02
10170aparc-Desikan lh area parstriangularisGCST900030920.02
10171CPA1 levelsGCST904688360.02
10172Basal cell carcinoma (PheCode 172.21)GCST904755820.02
10173Omega-6 fatty acid levelsGCST900929330.02
10174CD46/NID1 ratioGCST903138330.02
10175Linoleic acid levels (UKB data field 23449)GCST902695460.02
10176Chronic obstructive pulmonary disease in non-current smokersGCST900165940.02
10177FYB1/PDGFB ratioGCST903149120.02
10178Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T211ECGU0002110.02
10179DTI autoptx L1 ifo r tractGCST903851520.02
10180SLAMF8 levelsGCST904706520.02
10181Age when finished full-time education (weighted GWA)GCST902672810.02
10182CPB1 levelsGCST904688390.02
10183EPHB4 levelsGCST904691320.02
10184aparc-Desikan lh area postcentralGCST900030940.02
10185aparc-Desikan lh area fusiformGCST900030790.02
10186CD209/ITGAV ratioGCST903137530.02
10187CASP3/CRKL ratioGCST903136310.02
10188aparc-a2009s lh volume S-intrapariet+P-transGCST900029800.02
10189Risk taking (standard GWA)GCST902672980.02
10190KIRREL2 levelsGCST904696900.02
10191Total esterified cholesterol levelsGCST905000360.02
10192Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T458ECGA0004580.02
10193Phospholipids to total lipids in large HDL percentage (UKB data field 23634)GCST902697310.02
10194Types of physical activity in last 4 weeks - Strenuous sports | Physical activityUKBB000008740.02
10195Cholesterol levels in small LDLGCST900929560.02
10196OGFR levelsGCST904701180.02
10197F-strong flavour liking (derived food-liking factor)GCST900948510.02
10198Shellfish likingGCST900948380.02
10199Longitudinal peak diastolic strain rateGCST900190130.02
10200ThalamNuclei lh volume PfGCST900027220.02
10201Sleep duration | SleepUKBB000007770.02
10202ANG/RARRES2 ratioGCST903132710.02
10203Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T282ECGA0002820.02
10204LDL direct, adjusted by medication | Lipid or lipoprotein measurementUKBB000003880.02
10205CALCOCO1/INPPL1 ratioGCST903136030.02
10206Calculus of ureter (PheCode 594.3)GCST904761470.02
10207CEP85/ZBTB16 ratioGCST903140260.02
10208T1 FreeSurfer a2009s rh S temporal sup volumeGCST903851100.02
10209Free cholesterol levels in IDLGCST901326760.02
10210Fracture of lumbar spine and pelvisFING000005560.02
10211Own or rent accommodation lived in - Rent - from local authority, local council, housing association | HouseholdUKBB000006240.02
10212Prostate cancerGCST904751850.02
10213mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed)GCST904754580.02
10214Spirits likingGCST900948480.02
10215T1 CAT volume L TemporalOccipitalFusiformCortexGCST903840760.02
10216Immature fraction of reticulocytesGCST900023870.02
10217Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T180ECGA0001800.02
10218Pain type(s) experienced in last month - None of the above | PainUKBB000006310.02
10219Cholesteryl esters to total lipids in small VLDL percentage (UKB data field 23601)GCST902696980.02
10220Dronedarone medicationFING000004740.02
10221Participation in an health questionnaire (not invited vs invited)GCST900127940.02
10222SFTPA2 levelsGCST904706130.02
10223Hemoglobin A1c levelsGCST900187380.02
10224Coffee type - Ground coffee (include espresso, filter etc) | DietUKBB000001400.02
10225LBR/PSRC1 ratioGCST903153000.02
10226WWP2 levelsGCST904710800.02
10227T1 FreeSurfer DK rh supramarginal volumeGCST903857870.02
10228Diacylglycerol_34:0_[M+H-H2O]1+ levelsGCST900601810.02
10229Inflammatory markers and poor diet (confirmatory factor analysis Factor 30)GCST903093640.02
10230SEMA3G levelsGCST904705710.02
10231RARRES2/TFPI ratioGCST903157600.02
10232Sphingomyelin_32:1_[M+H]1+ levelsGCST900602250.02
10233Addison's diseaseGCST900118710.02
10234Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)FING000001430.02
102351-palmitoylglycerophosphoethanolamine levelsGCST902438350.02
10236Gamma glutamyl transpeptidaseGCST900187340.02
10237Orotidine levelsGCST902006810.02
10238Chronic obstructive pulmonary disease x current smoker interaction (main effect)GCST900165910.02
10239Processed meat consumptionGCST901329950.02
10240All dysplastic lesions of the cervix uteriFING000000600.02
10241Body-mass index, inverse-rank normalizedFING000002220.02
10242Total phospholipid levels in lipoprotein particlesGCST905001240.02
10243CXCL16 levelsGCST904689280.02
10244EDA2R levelsGCST904690670.02
10245ThalamNuclei rh volume VLpGCST900027550.02
10246potassium (maximum, inv-norm transformed)GCST904763040.02
10247FKBP4/SIRT2 ratioGCST903148410.02
10248TNFRSF13B levelsGCST904709050.02
10249Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classifiedFING000004320.02
10250TNFSF13B levelsGCST904709200.02
10251Platelet distribution width | Blood countUKBB000006480.02
10252Comfortable retirement (confirmatory factor analysis Factor 29)GCST903093630.02
10253Principal component-derived dietary pattern 19GCST901330240.02
10254T1 FreeSurfer DKT rh supramarginal volumeGCST903843770.02
10255HMBS/PSMG3 ratioGCST903150640.02
10256SUGT1/TBL1X ratioGCST903158970.02
10257PSMD9/UBAC1 ratioGCST903157350.02
10258FAS levelsGCST904691920.02
10259Prostate cancerGCST0060850.02
10260Asparagine levelsGCST902437580.02
10261Cholesterol, totalGCST0022210.02
10262Alanine aminotransferase levelsGCST900187230.02
10263EIF4G1/FKBP5 ratioGCST903146330.02
10264Total cholesterol levels in HDLGCST901326810.02
10265Methods of admission to hospital (recoded) - Elective admission: Booked | Summary AdministrationUKBB000004610.02
10266HIP1R levelsGCST904694530.02
10267Neutrophil percentage of white cellsGCST0046330.02
10268NAGA levelsGCST904699940.02
10269Mean corpuscular hemoglobin concentrationGCST900023290.02
10270CholecystitisFING000002740.02
10271FLT1/VEGFA ratioGCST903148580.02
10272Daytime napGCST0114940.02
10273CLEC1B/LBR ratioGCST903140950.02
10274GIPC2 levelsGCST904693470.02
10275Mean corpuscular haemoglobin concentration | Blood countUKBB000004480.02
10276Gestational age at birth (maternal effect)GCST902684190.02
10277Omega-6 fatty acids to total fatty acids percentageGCST904992100.02
10278MED18/ZBTB16 ratioGCST903154160.02
10279Basal cell carcinoma, excluding all cancers (controls excluding all cancers)FING000001420.02
10280CD164/CD99 ratioGCST903137400.02
10281TST levelsGCST904709820.02
10282Prevotellamassilia abundance in stoolGCST900325170.02
10283Tea intake (UKB data field 1488)GCST901329830.02
10284Fatty acid(20:3)_[M-H]1- levelsGCST900601170.02
10285Retinal nerve fibre layer (RNFL) thicknessGCST900142660.02
10286Total lipids in IDLGCST904975940.02
10287LYN/TACC3 ratioGCST903153500.02
10288Free cholesterol levels in small HDLGCST900929480.02
10289Tyrosine levelsGCST900929930.02
10290Birth asphyxiaFING000002180.02
10291CTRC/PLA2G1B ratioGCST903143100.02
10292GP6/SEMA4D ratioGCST903149710.02
10293Moderate-to-vigorous intensity physical activity during leisure timeGCST901043410.02
10294MINPP1 levelsGCST902419780.02
10295SCG2 levelsGCST904705380.02
10296Whole body fat mass (UKB data field 23100)GCST904281210.02
10297IDP dMRI TBSS L2 Superior cerebellar peduncle LGCST900041360.02
10298ICD10 O12: Gestational oedema and proteinuria without hypertensionGCST904542310.02
10299Neutrophill percentage | Blood countUKBB000004980.02
10300IDP dMRI ProbtrackX FA ptr lGCST900039440.02
10301Feeling guiltyGCST0069450.02
10302SIRPB1 levelsGCST904706400.02
10303Age at first sexual intercourseGCST900000450.02
10304Mild age-related type 2 diabetesGCST900264160.02
10305ADH4/CA5A ratioGCST903131890.02
10306Biological Mother: High blood pressureGCST904754900.02
10307Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)FING000007720.02
10308Free cholesterol to total lipids ratio in small VLDLGCST900929730.02
10309CDH17/GALNT3 ratioGCST903139400.02
10310GM1 ganglioside (d18:1/16:0) levelsGCST900247240.02
10311CCN5 levelsGCST904685910.02
10312ALDH1A1/PKLR ratioGCST903132450.02
10313Chronic dermatitis due to solar radiation (PheCode 938.2)GCST904762880.02
10314Use of sun/uv protection | Sun exposureUKBB000008870.02
10315Financial situation satisfaction | Mental healthUKBB000002490.02
10316Smoking status (standard GWA)GCST902673020.02
10317Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)FING000007700.02
10318DSG3/FABP9 ratioGCST903145590.02
10319Linoleic acid levelsGCST905022940.02
10320Myo-inositol levelsGCST902435270.02
10321Shortness of breath (PheCode 512.7)GCST904760400.02
10322CataractsGCST900185940.02
10323HSIL lesion of the cervix uteriFING000006240.02
10324Diseases of oesophagus, stomach and duodenumFING000004280.02
10325SF3B4/SIRT2 ratioGCST903158380.02
10326Peripheral or central vertigo (PheCode 386.2)GCST904759070.02
10327HippSubfield lh volume Whole-hippocampal-headGCST900026880.02
10328IL34 levelsGCST904695930.02
10329ST3GAL1 levelsGCST904707520.02
10330Raynauds phenomenon diseaseGCST902717130.02
10331High light scatter reticulocyte percentage | Blood countUKBB000003270.02
10332Basophil percentage of granulocytesGCST0046340.02
10333EBAG9/TBCB ratioGCST903145670.02
10334AGXT/MME ratioGCST903132070.02
10335BACH1/SNAP23 ratioGCST903134460.02
10336hematocrit (maximum, inv-norm transformed)GCST904753380.02
10337MAP3K5/MAVS ratioGCST903153790.02
10338Type 2 diabetesGCST0101180.02
10339IDP dMRI TBSS L1 Sagittal stratum LGCST900041060.02
10340Acquired hypothyroidism (PheCode 244.2)GCST904756500.02
10341Omega-3 fatty acids to total fatty acids percentageGCST905024490.02
10342Secondary thrombocytopenia (PheCode 287.32)GCST904758100.02
10343CLEC6A levelsGCST904687770.02
10344Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T424ECGU0004240.02
10345Cholesterol | Blood biochemistryUKBB000001340.02
10346red cell diameter width (RDW, maximum, inv-norm transformed)GCST904763570.02
10347Lager likingGCST900947890.02
10348TRIM21 levelsGCST904709640.02
10349Total bilirubin levelsGCST902786430.02
10350GRPEL1/MME ratioGCST903149920.02
10351rfMRI connectivity (ICA100 edge 619)GCST900054720.02
10352Left-hemisphere default mode network to hippocampus white-matter structural connectivityGCST903027710.02
10353AFP levelsGCST902786150.02
10354DementiaFING000003910.02
10355Docosahexaenoic acid to total fatty acids percentageGCST904972700.02
10356LDL cholesterol levelsGCST904983460.02
10357CCL5/LAMA4 ratioGCST903137030.02
10358FCER2/TCL1A ratioGCST903147900.02
10359NRCAM levelsGCST904700820.02
10360Alanine levelsGCST904970860.02
10361Urine N1,N12-diacetylspermine levels in chronic kidney diseaseGCST902656830.02
10362SNRPB2 levelsGCST904706970.02
10363ANPEP/NT5E ratioGCST903132740.02
10364Bioavailable testosterone levelsGCST900121030.02
10365DTI autoptx L2 ifo r tractGCST903851790.02
10366Basal cell carcinomaGCST900134100.02
10367DTI autoptx L2 ptr l tractGCST903851850.02
10368Phospholipids in LDLGCST904984320.02
10369BCAM/SEMA7A ratioGCST903134760.02
10370Mental and behavioural disorders due to use of tobacco | Mental and behavioural disorders due to psychoactive substance useUKBB000004600.02
10371PDGFB/SPINT2 ratioGCST903156290.02
10372DPEP1 levelsGCST900903020.02
10373GALNT10/SEMA7A ratioGCST903149150.02
10374All dysplastic lesions of the cervix uteri, vagina or vulvaFING000000610.02
10375Symptoms concerning nutrition, metabolism, and development (PheCode 1002)GCST904755560.02
10376Coffee type: Ground coffee (include espresso, filter etc) (UKB data field 1508_3)GCST900418030.02
10377ST8SIA1 levelsGCST904707540.02
10378CDKN1A/TXLNA ratioGCST903139790.02
10379CAMKK1/FOXO1 ratioGCST903136130.02
10380T1 CAT volume L LeftAccumbensGCST903841080.02
10381F-strong alcohol liking (derived food-liking factor)GCST900948500.02
10382Other diseases of urinary systemFING000010130.02
10383PGA4 levelsGCST904702160.02
10384Frequency of friend/family visits | Social supportUKBB000002620.02
10385Phospholipids to Total Lipids in IDL percentageGCST904976420.02
10386Frequency of travelling from home to job workplace | EmploymentUKBB000002690.02
10387Vigorous physical activityGCST0060980.02
10388Urine glycocholenate sulfate* levels in chronic kidney diseaseGCST902652920.02
10389IL1RN/LGALS9 ratioGCST903151600.02
10390FGFR4 levelsGCST904692340.02
10391Cholesteryl esters to total lipids ratio in large LDLGCST900928590.02
10392Parkinson's disease or first degree relation to individual with Parkinson's diseaseGCST0093250.02
10393Hearing aid user (UKB data field 3393)GCST900437410.02
10394KLK11 levelsGCST900120120.02
10395Mineral and other dietary supplements - Zinc | MedicationUKBB000004760.02
10396Usual side of head for mobile phone use - Equally left and right | Electronic device useUKBB000008880.02
10397Omega-3 fatty acid levelsGCST905020610.02
10398Migraine with auraFING000008190.02
10399Duration of heavy DIY | Physical activityUKBB000001950.02
10400IDP dMRI TBSS OD Cerebral peduncle LGCST900044170.02
10401DTI autoptx L1 atr l tractGCST903851410.02
10402Left-hemisphere control network to left-hemisphere control network white-matter structural connectivityGCST903027430.02
10403Glucose | Blood biochemistryUKBB000002880.02
10404CDH17/DSG2 ratioGCST903139390.02
10405Glomerular filtration rate in non diabetics (creatinine)GCST0034010.02
10406Polyneuropathy in diabetes (PheCode 250.6)GCST904756860.02
10407TP53BP1 levelsGCST904709360.02
10408Cholesterol levels (UKB data field 30690)GCST904680660.02
10409Other soft tissue disorders, not elsewhere classifiedFING000010990.02
10410IDP dMRI TBSS ICVF Posterior limb of internal capsule RGCST900043450.02
10411SORT1/ST6GAL1 ratioGCST903158690.02
10412Other disorders of glucose regulation and pancreatic internal secretionFING000010280.02
10413BA-exvivo rh area BA1GCST900032210.02
10414Irregular mensesFING000007010.02
10415IDP dMRI ProbtrackX ICVF cst rGCST900043840.02
10416GBP6 levelsGCST902413680.02
10417CA5A/GSTA1 ratioGCST903135910.02
10418Transient global amnesiaFING000013740.02
10419Total lipids in small HDL (UKB data field 23573)GCST902696700.02
10420Cream likingGCST900947460.02
10421ANXA3/ENO2 ratioGCST903132810.02
10422aseg lh volume VentralDCGCST900026270.02
10423Restless legs syndrome (PheCode 327.71)GCST904758290.02
10424RCC1 levelsGCST904704430.02
10425Omega-3 fatty acids to total fatty acids percentageGCST905020810.02
10426Tyrosine levelsGCST905001430.02
10427Asthma | respiratoryUKBB000000540.02
10428Hair colour (natural, before greying): Black (UKB data field 1747_5)GCST900418400.02
10429BST2/CEACAM1 ratioGCST903135370.02
10430Cereal bar likingGCST900947280.02
10431BCR/GOPC ratioGCST903134910.02
10432Cholesteryl Esters to Total Lipids in Very Small VLDL percentageGCST905007540.02
10433ZBTB17 levelsGCST904710960.02
10434Platelet count during third trimester of pregnancyGCST903022260.02
10435CLTA levelsGCST904687910.02
10436CEACAM8/PGLYRP1 ratioGCST903140030.02
10437Lysophosphatidylcholine (20:3) [sn1] levelsGCST900241690.02
10438SLAMF7/TXNDC15 ratioGCST903158500.02
10439Neoplasm of uncertain behavior of skin (PheCode 173)GCST904755850.02
10440BLVRB/CA3 ratioGCST903135230.02
10441Actinic keratosis (PheCode 702.1)GCST904762040.02
10442SLC5A8 levelsGCST902428500.02
10443CSTB levelsGCST904688980.02
10444IDP dMRI ProbtrackX OD ilf rGCST900044650.02
10445T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 12)GCST903208310.02
10446Use of disulfiram, acamprosate or naltrexoneFING000014100.02
10447Principal component-derived dietary pattern 4GCST901330090.02
10448Facial skin colour (CIELAB index b* value)GCST900200560.02
10449Clinical LDL cholesterol levelsGCST904972190.02
10450CD80 on monocyteGCST900020390.02
10451LPCAT2/SERPINB8 ratioGCST903153280.02
10452SERPINA11 levelsGCST904705800.02
10453Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDLGCST900930430.02
10454CEACAM20 levelsGCST904686930.02
10455Left-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST903027060.02
10456Primary angle-closure glaucomaFING000012100.02
10457Secondary hypothyroidism (PheCode 244.1)GCST904756490.02
10458Right-hemisphere somatomotor network to amygdala white-matter structural connectivityGCST903027990.02
10459F-fatty food liking (derived food-liking factor)GCST900947610.02
10460CPA1/CPB1 ratioGCST903142020.02
10461BAG6/USP8 ratioGCST903134510.02
10462Cholelithiasis | Disorders of gallbladder, biliary tract and pancreasUKBB000001320.02
10463EPO levelsGCST904691360.02
10464Microalbumin in urine | Urine assaysUKBB000004670.02
10465Triglycerides to total lipids ratio in small VLDLGCST900929790.02
10466Symptoms involving digestive system (PheCode 561)GCST904760690.02
10467HippSubfield rh volume CA4-bodyGCST900027050.02
10468Total Lipids in LDLGCST904983960.02
10469Juvenile rheumatoid arthirtisFING000007060.02
10470Qualifications - None of the above | EducationUKBB000007290.02
10471Completion of the aide-memoireGCST900127930.02
10472IDP dMRI TBSS L1 Body of corpus callosumGCST900040780.02
10473Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T458ECGU0004580.02
10474Crohn disease (strict definition, require KELA, min 2 HDR)FING000003660.02
10475AmygNuclei rh volume Basal-nucleusGCST900026590.02
10476aparc-DKTatlas rh volume superiorparietalGCST900029200.02
10477Mother's age | Family historyUKBB000004840.02
10478Statin-associated type 2 diabetes mellitusGCST906525170.02
10479IDP dMRI TBSS L1 Cerebral peduncle LGCST900040900.02
10480DorsalgiaFING000004720.02
10481NT5C levelsGCST904700920.02
10482Sum eosinophil basophil countsGCST0046240.02
10483aparc-Desikan rh volume superiorparietalGCST900028290.02
10484KLK8 levelsGCST904697070.02
10485Tobacco useFING000013650.02
10486Other mental disorder | mental disordersUKBB000006140.02
10487INPP1/TBCC ratioGCST903151800.02
10488CLPS/PRSS2 ratioGCST903141410.02
10489Been in a confiding relationship as an adult | Traumatic eventsUKBB000000880.02
104901-stearoyl-2-docosahexaenoyl-gpc (18:0/22:6) levelsGCST902000460.02
10491EDAR levelsGCST904690680.02
10492REST UKBBICA NODEamps25 0007GCST903854900.02
10493Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T280ECGU0002800.02
10494PVALB levelsGCST904703930.02
10495Diabetes (weighted GWA)GCST902672790.02
10496SERPINB6/TXNDC5 ratioGCST903158320.02
10497Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T279ECGA0002790.02
10498IGSF8/VSIR ratioGCST903151410.02
10499Concentration of large LDL particlesGCST904980370.02
10500Mineral and other dietary supplements - None of the above | MedicationUKBB000004740.02
10501Other disorders of earFING000010230.02
10502Phosphatidylinositol (20:0_20:4) levelsGCST900250830.02
10503Cardiorespiratory fitness (vo2 max)GCST900933170.02
10504Principal component-derived dietary pattern 30GCST901330350.02
10505RRM2B levelsGCST904705000.02
10506Sleep related movement disorders (PheCode 327.7)GCST904758270.02
10507Glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) levelsGCST902001050.02
10508Non-cancer illness code, self-reported - gout | Medical conditionsUKBB000005120.02
10509Principal component-derived dietary pattern 9GCST901330140.02
10510Mean platelet volumeGCST900023950.02
10511CALCOCO1/TJAP1 ratioGCST903136110.02
10512ICD10 C61: Malignant neoplasm of prostateGCST900438940.02
10513UBAC1 levelsGCST904709990.02
10514SORT1 levelsGCST904707100.02
10515MAN2B2 levelsGCST904698440.02
10516CCL20 levelsGCST900120770.02
10517LMOD1 levelsGCST904697830.02
10518Mood [affective] disordersFING000008360.02
10519T1 CAT volume R RightThalamusGCST903840970.02
10520F-dairy liking (derived food-liking factor)GCST900947510.02
10521Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T457ECGA0004570.02
10522Atopic dermatitisFING000001250.02
10523OLFM4 levelsGCST904701210.02
10524T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 70)GCST903208890.02
10525Polyunsaturated fatty acid levelsGCST905026180.02
10526CD22/FCER2 ratioGCST903137560.02
10527Juvenile arthritis (FINNGEN)FING000007040.02
10528APOB levelsGCST904971370.02
10529Sleep disorders (combined)FING000013110.02
10530MMP1/MMP3 ratioGCST903154610.02
10531HPCAL1/NUDC ratioGCST903150740.02
10532Restless legs syndromeGCST904353870.02
10533HippSubfield rh volume Whole-hippocampusGCST900027110.02
10534IPCEF1/SERPINE1 ratioGCST903151840.02
10535Other/unspecified dorsalgiaFING000011240.02
10536PRSS2 levelsGCST904703430.02
10537Alcohol consumptionGCST901330030.02
10538Croissant likingGCST900947480.02
10539AGXT/GRPEL1 ratioGCST903132050.02
10540Mean diameter of VLDL particlesGCST901327340.02
10541Psoas tendinitisFING000012210.02
10542Lymphocyte percentage | Blood countUKBB000004120.02
10543Plasma ascorbic acid 2-sulfate levels in chronic kidney diseaseGCST902648320.02
10544Cervicobrachial syndromeFING000002660.02
10545SLC4A1 levelsGCST904706630.02
10546CPB1/PRSS2 ratioGCST903142110.02
10547Cereal type: Other (e.g. Cornflakes, Frosties) (UKB data field 1468_5)GCST901329730.02
10548Cerebrospinal fluid S-1-pyrroline-5-carboxylate levelsGCST903182350.02
10549USP8/WASF1 ratioGCST903159440.02
10550Attention deficit hyperactivity disorder (ADuLT model adjusted for sex)GCST902751360.02
10551aseg lh intensity PallidumGCST900037710.02
10552Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levelsGCST900257430.02
10553Acceptance of an invitation to participate in a mental health questionnaireGCST900127920.02
10554GZMH levelsGCST904694250.02
10555Nummular dermatitisFING000008930.02
10556RNASE3 levelsGCST904704770.02
10557Attention deficit hyperactivity disorder (adjusted for age, sex)GCST902751470.02
10558SEZ6L levelsGCST904706070.02
10559Feeling hurtGCST0069510.02
10560BMP7 levelsGCST900881570.02
10561Diabetes mellitus (UKB data field 2443)GCST900436270.02
10562KLF4 levelsGCST904696940.02
10563Mean corpuscular hemoglobin concentrationGCST900187450.02
10564KL levelsGCST900912460.02
10565Omega-6 fatty acid levelsGCST905021010.02
10566IRAK1/SPRY2 ratioGCST903151960.02
10567Hemoglobin concentrationGCST0046150.02
10568GLB1/GUSB ratioGCST903149310.02
10569ANXA4/HSPB1 ratioGCST903132920.02
10570ICAM2/IL7R ratioGCST903151170.02
10571IDP dMRI TBSS L3 Superior cerebellar peduncle LGCST900041840.02
10572DECR1/MAP2K6 ratioGCST903144470.02
10573ANXA3/BID ratioGCST903132790.02
10574IDP T1 FIRST right pallidum volumeGCST900024430.02
10575CLEC1B/EGF ratioGCST903140890.02
10576Phospholipid levels in very large HDLGCST901326420.02
10577Number of non-cancer illnesses (standard GWA)GCST902672900.02
10578SPARCL1 levelsGCST902428700.02
10579Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)GCST0036580.02
10580GAS6/NOTCH1 ratioGCST903149180.02
10581Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T459ECGU0004590.02
10582AHSP levelsGCST904682640.02
10583CRACR2A/LBR ratioGCST903142280.02
10584INPP5J levelsGCST904696180.02
10585CSF1/IFNGR1 ratioGCST903142830.02
10586Omega-6 fatty acid levelsGCST905025020.02
10587Fluid intelligence score (baseline)GCST905658420.02
10588F9/FETUB ratioGCST903147460.02
10589NINJ1 levelsGCST904700490.02
10590Hair colour (natural, before greying) - Dark brown | Sun exposureUKBB000002970.02
10591aseg lh volume Accumbens-areaGCST900026260.02
10592Cysteine-glutathione disulfide levelsGCST901997840.02
10593Principal component-derived dietary pattern 20GCST901330250.02
10594HematocritGCST0046040.02
10595Types of physical activity in last 4 weeks - Walking for pleasure (not as a means of transport) | Physical activityUKBB000008750.02
10596C20:4 Lysophosphatidylcholine levels in chronic kidney diseaseGCST902575700.02
10597Light-intensity physical activity durationGCST900614210.02
10598CXCL5/SPARC ratioGCST903143550.02
10599FADD/PTPN6 ratioGCST903147750.02
10600Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T455ECGA0004550.02
10601white blood cell count (WBC, maximum, inv-norm transformed)GCST904764510.02
10602AXIN1/CDKN1A ratioGCST903134030.02
10603Volume of right basal nucleusGCST904750150.02
10604GKN1 levelsGCST904693530.02
10605Cough (PheCode 512.8)GCST904760410.02
10606wg rh intensity-contrast lingualGCST900038390.02
10607Urine proline levels in chronic kidney diseaseGCST902658730.02
10608Smoking status (weighted GWA)GCST902673030.02
10609DTI TBSS L1 Anterior corona radiata LGCST903844510.02
10610Codeine or tramadol medicationFING000003110.02
10611Cholesterol to total lipids ratio in small VLDLGCST900929690.02
10612Phospholipids to Total Lipids in Large LDL percentageGCST904980710.02
10613Adenomyosis (Endometriosis of uterus)FING000000420.02
10614KITLG levelsGCST902748330.02
10615Number of treatments/medications taken | MedicationsUKBB000005420.02
10616Blood urea nitrogen levelsGCST902786230.02
10617Inflammatory bowel disease, strict (require KELA)FING000006750.02
10618PCDH1/TNFRSF11A ratioGCST903156080.02
10619Acute sinusitisFING000000310.02
10620BIN2/EREG ratioGCST903135030.02
10621Plasma N,N,N-trimethyl-5-aminovalerate levels in chronic kidney diseaseGCST902656710.02
10622Estimated glomerular filtration rate (creatinine)GCST901036340.02
10623CDKN1A/ENO2 ratioGCST903139690.02
10624Linoleic acid levelsGCST905020100.02
10625rfMRI connectivity (ICA100 edge 387)GCST900052400.02
10626IntelligenceGCST0062500.02
10627Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007160.02
10628Phospholipids to total lipids ratio in medium LDLGCST900929130.02
10629Recent feelings of tiredness or low energy | DepressionUKBB000007400.02
10630Seen doctor (GP) for nerves, anxiety, tension or depression | Mental healthUKBB000007650.02
10631Acute pancreatitisGCST902553750.02
10632Sphingomyelin (d18:1/20:0, d16:1/22:0) levelsGCST902000010.02
10633VWC2L levelsGCST904710630.02
10634CELA2A levelsGCST904687010.02
10635CABP2 levelsGCST904685190.02
10636IDP dMRI ProbtrackX L1 cgc rGCST900042510.02
10637CEACAM21 levelsGCST904686940.02
10638Noninfective enteritis and colitisFING000008810.02
10639NFATC3 levelsGCST904700340.02
10640PEAR1/SCARF1 ratioGCST903156420.02
10641PHLDB1 levelsGCST904702250.02
10642Salami likingGCST900948250.02
10643aseg rh intensity PallidumGCST900037850.02
10644Medication for pain relief, constipation, heartburn - Laxatives (e.g. Dulcolax, Senokot) | MedicationUKBB000004560.02
10645Porridge likingGCST900948150.02
10646Lung cancerGCST900186550.02
10647neutrophil (absolute count, maximum, inv-norm transformed)GCST904755260.02
10648ESAM/THPO ratioGCST903147190.02
10649Current employment status - In paid employment or self-employed | EmploymentUKBB000001580.02
10650aseg rh volume Accumbens-areaGCST900026430.02
10651Fasting glucoseGCST900022320.02
10652RGMB/TNFRSF21 ratioGCST903157720.02
10653NeuroticismGCST0029200.02
10654Chronic myeloproliferative diseaseFING000002940.02
10655HippSubfield lh volume Whole-hippocampusGCST900026890.02
10656DTI TBSS MD Fornix cres+Stria terminalis RGCST903846100.02
10657AHSP/BLVRB ratioGCST903132140.02
10658BBQ/grilled meat likingGCST900946980.02
10659Phosphatidylethanolamine_40:6_[M-H]1- levelsGCST900603650.02
10660Omega-6 fatty acid levelsGCST905021030.02
10661Chronic sinusitis (PheCode 475)GCST904760200.02
10662Depression (broad)GCST0059020.02
10663KLK4 levelsGCST904697040.02
10664Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T472ECGA0004720.02
10665CD200R1/CLEC4G ratioGCST903137480.02
10666Remnant cholesterol (non-HDL, non-LDL -cholesterol)GCST904993400.02
10667MAP4K5/TBCB ratioGCST903153840.02
10668IDP T1 FAST ROIs R cerebellum crus IGCST900025710.02
10669Red blood cell erythrocyte distribution width (UKB data field 30070)GCST904680990.02
10670CD163/SIGLEC1 ratioGCST903137390.02
10671T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3)GCST903208220.02
10672Daytime dozing / sleeping (narcolepsy) | SleepUKBB000001640.02
10673Etiocholanolone glucuronide levelsGCST901999640.02
10674Concentration of IDL particlesGCST904976060.02
10675AsthmaGCST0100420.02
10676Chromatiales abundance in stoolGCST900323180.02
10677CPA1/PRSS2 ratioGCST903142060.02
10678GPRC5C levelsGCST904693980.02
10679Cholesteryl esters to total lipids ratio in medium VLDLGCST900929190.02
10680Bacterial pneumoniaeFING000001390.02
10681Principal component-derived dietary pattern 44GCST901330490.02
10682Crohns diseaseGCST904681210.02
10683Age at first sexual intercourseGCST900000460.02
10684FLT1 levelsGCST904692490.02
10685Lymphocyte countGCST900023160.02
10686Types of transport used (excluding work) - Cycle | Physical activityUKBB000008770.02
10687ZNRD2 levelsGCST904711030.02
10688CPB1/REG1A ratioGCST903142120.02
10689SPINK1 levelsGCST904707210.02
10690CD160 levelsGCST904685990.02
10691T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60)GCST903208790.02
10692T1 CAT volume L VIIIbGCST903841300.02
10693Total cholesterol levelsGCST905000150.02
10694Personal history of certain other diseases | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000006420.02
10695MNDA levelsGCST904699270.02
10696BSG/TNFRSF4 ratioGCST903135360.02
10697Rheumatoid arthritisFING000012670.02
10698HippSubfield lh volume CA4-headGCST900026820.02
10699Degenerative skin conditions and other dermatoses (PheCode 702)GCST904762020.02
10700SPOCK1 levelsGCST904707300.02
10701HippSubfield rh volume hippocampal-fissureGCST900026940.02
10702Bifidobacterium catenulatum abundance in stoolGCST900322240.02
10703Skin and soft tissue infectionsGCST900134110.02
10704MST1 levelsGCST904699520.02
10705IL18BP/ROR1 ratioGCST903151550.02
10706Lymphocyte percentage (UKB data field 30180)GCST904680830.02
107071-ribosyl-imidazoleacetate levelsGCST901998150.02
10708Uterine fibroidsGCST904619580.02
10709Creatinine levelsGCST901327190.02
10710Mineral and other dietary supplements - Glucosamine | MedicationUKBB000004730.02
10711Hemoglobin A1c (HbA1c, minimum, inv-norm transformed)GCST904750970.02
10712Methods of admission to hospital (recoded) - Emergency admission: A&E | Summary AdministrationUKBB000004640.02
10713mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed)GCST904754620.02
10714Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T460ECGU0004600.02
10715CLPS/PLA2G1B ratioGCST903141400.02
10716CholecystectomyFING000002730.02
10717Ever smoked | SmokingUKBB000002210.02
10718aparc-DKTatlas lh area precentralGCST900032560.02
10719Degeneration of intervertebral disc (PheCode 722.6)GCST904762380.02
10720MAX/STK24 ratioGCST903154040.02
10721Nontoxic goitre/thyroid noduleFING000008870.02
10722Abdominal pain | symptomsUKBB000000030.02
10723Omega-6 fatty acid levelsGCST905025140.02
10724ThalamNuclei rh volume PfGCST900027460.02
10725SarcoidosisGCST905034830.02
10726CD86 levelsGCST904686540.02
10727ARHGEF12/IRAK4 ratioGCST903133500.02
10728Leisure/social activities - Adult education class | Social supportUKBB000003980.02
10729Medication use (HMG CoA reductase inhibitors)GCST900187690.02
10730AppendectomyFING000001040.02
10731HBEGF/PLXNA4 ratioGCST903150360.02
10732CRACR2A/DNMBP ratioGCST903142260.02
10733Personality disorders (more control exclusions)FING000011630.02
10734CPA1/CTRC ratioGCST903142040.02
10735Bicarbonate (mean, inv-norm transformed)GCST904751480.02
10736Creatinine levelsGCST900928150.02
10737Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditionsUKBB000000980.02
10738Total cholesterol minus HDL-C levelsGCST900929300.02
10739Glomerular filtration rate (creatinine)GCST0033720.02
10740KIR2DL2 levelsGCST904696840.02
10741Thyroid cancer (PheCode 193)GCST904756000.02
10742Neutrophil percentage of white cellsGCST900023990.02
10743SCARF1/SUSD1 ratioGCST903158110.02
10744Open biteFING000009030.02
10745Coffee type - Decaffeinated coffee (any type) | DietUKBB000001390.02
10746Non-cancer illness code, self-reported - asthma | Medical conditionsUKBB000005060.02
10747Current SmokerFING000003710.02
10748Cholesterol to Total Lipids in Large LDL percentageGCST904979380.02
10749ATP5IF1/FXN ratioGCST903133860.02
10750IL15/NCR1 ratioGCST903151500.02
10751Type 2 diabetesGCST900860720.02
10752Right ventricular stroke volumeGCST902681220.02
10753Pain in limb (PheCode 773)GCST904762700.02
10754PNLIP levelsGCST904702750.02
10755Sleep apnoeaFING000013090.02
10756Types of physical activity in last 4 weeks - Other exercises (eg: swimming, cycling, keep fit, bowling) | Physical activityUKBB000008730.02
10757Do you smoke now?GCST904763890.02
10758Roast chicken likingGCST900948210.02
10759Raw carrot likingGCST900948180.02
10760TNFAIP8 levelsGCST904708980.02
10761ThalamNuclei rh volume MGNGCST900027370.02
10762CD27/NECTIN4 ratioGCST903137750.02
10763REG1A/TFF3 ratioGCST903157640.01
10764CALCOCO1/IKBKG ratioGCST903136020.01
10765STAMBP/WWP2 ratioGCST903158880.01
10766Sleep apnoea, including avohilmoFING000013100.01
10767APOL1 levelsGCST904683410.01
10768ARSA levelsGCST904683680.01
10769Physical activity (confirmatory factor analysis Factor 23)GCST903093570.01
10770AXIN1/ITGB1BP2 ratioGCST903134120.01
10771Polymyalgia rheumaticaFING000011880.01
10772Multiple sclerosisGCST904758330.01
10773Alanine levels (UKB data field 23460)GCST902695570.01
10774Bread intake | DietUKBB000001050.01
10775EPS8L2/LGALS4 ratioGCST903146850.01
10776Pulmonary embolism and infarction, acute (PheCode 415.11)GCST904759460.01
10777Strenuous sports or other exercisesGCST0061000.01
10778Low back painFING000007300.01
10779DTI TBSS MD Body of corpus callosumGCST903845750.01
10780A1BG levelsGCST904681850.01
10781Linoleic acid levelsGCST905023060.01
10782Ulcerative colitisGCST904467950.01
10783Neutrophill percentage (UKB data field 30200)GCST904680930.01
10784Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T245ECGU0002450.01
10785Alcohol dependenceFING000000500.01
10786Curry likingGCST900947500.01
10787Medication use (drugs affecting bone structure and mineralization)GCST900187730.01
10788Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905023970.01
10789X-13435 levelsGCST902438110.01
10790Non-allergic asthma (mode) (more control exclusions)FING000008690.01
10791Milky sweets likingGCST900948020.01
10792ISEI occupational scoreGCST904461600.01
10793FOXO1/NUB1 ratioGCST903148740.01
10794Atrophic disorders of skinFING000001290.01
10795FCRL1/TNFRSF13C ratioGCST903147960.01
10796Hair colour (natural, before greying): Red (UKB data field 1747_2)GCST900418370.01
10797Type 1 diabetesGCST904320660.01
10798VSIG10 levelsGCST904710500.01
10799AZU1/CEACAM8 ratioGCST903134240.01
10800Neoplasm of uncertain behavior (PheCode 199)GCST904756060.01
10801SMAD1/ZBTB16 ratioGCST903158530.01
10802PolyarthropathiesFING000011800.01
10803DLL1/TGFBR2 ratioGCST903144990.01
10804BTN2A1/CSF1 ratioGCST903135410.01
10805Total cholesterol minus HDL-C levelsGCST904991290.01
10806Other and unspecified urticariaFING000009570.01
10807rfMRI connectivity (ICA25 edge 103)GCST900047460.01
10808LCN2 levelsGCST904697470.01
10809Dermatophytosis of nail (PheCode 110.11)GCST904755620.01
10810Malignant neoplasm, excluding all cancers (controls excluding all cancers)FING000007800.01
10811Biological Father: Cancer, SkinGCST904752400.01
10812CholelithiasisFING000002750.01
10813Medication use (adrenergics, inhalants)GCST900187790.01
10814CCL17/PDGFB ratioGCST903136880.01
10815Melanomas of skin, dx or hx (PheCode 172.1)GCST904755770.01
10816CNDP1/EGFR ratioGCST903141460.01
10817TGFBR2/TNFRSF1A ratioGCST903159180.01
10818Malignant melanomaGCST904681410.01
10819Linoleic acid to total fatty acids percentageGCST905020250.01
10820Lymphocyte percentage of white cellsGCST900023890.01
10821SDC4 levelsGCST904705590.01
10822Linoleic acid levelsGCST900928800.01
10823Dizziness and giddiness (Light-headedness and vertigo) (PheCode 386.9)GCST904759080.01
10824All anxiety disordersFING000000590.01
10825Age at first sexual intercourseGCST900000470.01
10826Total lipid levels in lipoprotein particlesGCST905000850.01
10827GSTA3/KRT18 ratioGCST903149970.01
10828Educational attainmentGCST0025980.01
10829FCRL5/MZB1 ratioGCST903148040.01
10830Postinflammatory pulmonary fibrosis (PheCode 502)GCST904760320.01
10831Paraproteinemia (PheCode 270.32)GCST904757100.01
10832CD74/TNFRSF21 ratioGCST903138970.01
10833Alkylphosphatidylcholine (O-32:1) levelsGCST900249230.01
10834B4GALT1/B4GAT1 ratioGCST903134290.01
10835Lower back pain or/and sciaticaFING000007310.01
10836Stearate 18:0 levelsGCST902434310.01
10837Cholesteryl ester_18:2_[M+NH4]1+ levelsGCST900602200.01
10838Mouth/teeth dental problems - Loose teeth | MouthUKBB000004870.01
10839SH2D1A levelsGCST904706170.01
10840TinnitusGCST904482420.01
10841CD79B/CKAP4 ratioGCST903138980.01
10842eGFR in diabetes mellitus (loose) (minimal adjustment)GCST906247830.01
10843Lifetime number of sexual partners | Sexual factorsUKBB000004060.01
10844KLK15 levelsGCST904697010.01
10845CCL18 levelsGCST904685700.01
10846ART3 levelsGCST904683700.01
10847X-12707 levelsGCST902005020.01
10848Loneliness, isolation | Mental healthUKBB000004080.01
10849Cholesteryl Esters to Total Lipids in Large LDL percentageGCST904979670.01
10850Calcific tendinitis of shoulderFING000002350.01
10851ADAMTS15/SULT2A1 ratioGCST903131710.01
10852Ovarian cystFING000011320.01
10853Lichen simplex chronicus and prurigoFING000007250.01
10854HLA-DMA levelsGCST902414480.01
10855lymphocyte (absolute count, mean, inv-norm transformed)GCST904754260.01
10856T1 CAT volume L LeftPutamenGCST903841000.01
10857ENO2/TACC3 ratioGCST903146700.01
10858FCRL1/TCL1A ratioGCST903147950.01
10859Age completed full time education | EducationUKBB000000130.01
10860Urinary tryptophan to urinary creatinine ratioGCST904517480.01
10861Emotionally unstable personality disorderFING000004950.01
10862NADK/S100A11 ratioGCST903155130.01
10863Cholesteryl ester levels in LDLGCST900928840.01
10864AXIN1/BACH1 ratioGCST903134000.01
10865CD274 levelsGCST904686130.01
10866Total cholesterol levels in LDLGCST901326860.01
10867Hearing difficultyGCST902457740.01
10868CEACAM8/MMP9 ratioGCST903140020.01
10869Suggestive for eosinophilic asthmaFING000013440.01
10870Glycosyl ceramide (d18:1/20:0, d16:1/22:0) levelsGCST902001450.01
10871KLRD1/LY9 ratioGCST903152610.01
10872Disorders of iron metabolism (PheCode 275.1)GCST904757430.01
10873BCR/VASH1 ratioGCST903134990.01
10874PLA2G4A/SPINT2 ratioGCST903156710.01
10875eGFR in diabetes mellitus (full adjustment)GCST906247860.01
10876Other arthritis (FG)FING000009640.01
10877Testosterone levelsGCST904834870.01
10878T1 CAT volume R RightAccumbensGCST903841090.01
10879CRIM1/NRP2 ratioGCST903142610.01
10880CD27/TGFBR2 ratioGCST903137760.01
10881TNFRSF10C levelsGCST904709010.01
10882DNPH1/PDGFB ratioGCST903145270.01
10883chloride (maximum, inv-norm transformed)GCST904751920.01
10884Enteropathic arthropathiesFING000005080.01
10885Basophil percentage of white cells varianceGCST905656880.01
10886TSHB levelsGCST904709740.01
10887aparc-DKTatlas rh area postcentralGCST900032850.01
10888Physical activity (Total log acceleration 10pm-12am)GCST900614200.01
10889Hair colour (natural, before greying): Dark brown (UKB data field 1747_4)GCST900418390.01
10890CCL28/PDGFB ratioGCST903136950.01
10891PTH levelsGCST904703720.01
10892Total lipid levels in lipoprotein particlesGCST900929890.01
10893Hearing difficulty and hearing difficulty with background noiseGCST902457680.01
10894PLA2G1B/PRSS2 ratioGCST903156650.01
10895Qualifications - NVQ or HND or HNC or equivalent | EducationUKBB000007300.01
10896YOD1 levelsGCST904710900.01
10897Allergic contact dermatitisFING000000680.01
10898Left-hemisphere somatomotor network to left-hemisphere default mode network white-matter structural connectivityGCST903026740.01
10899Cis-4-decenoylcarnitine (C10:1) metabolite levelGCST906157290.01
10900Hemoglobin A1c (HbA1c, maximum, inv-norm transformed)GCST904750910.01
10901Reason for glasses/contact lenses - For 'astigmatism' | EyesightUKBB000007330.01
10902Autoimmune hyperthyroidismFING000001340.01
10903ENPP2/TNFRSF11B ratioGCST903146720.01
10904Ratio of bis-allylic bonds to double bonds in lipidsGCST901327440.01
10905Total cholesterol levelsGCST902786440.01
10906Serum copper levelsGCST901005240.01
10907NFASC levelsGCST904700310.01
10908Hemoglobin A1c (HbA1c, mean, inv-norm transformed)GCST904750940.01
10909Nervonoylcarnitine (C24:1) levelsGCST902001430.01
10910Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T444ECGU0004440.01
10911IL15 levelsGCST904695560.01
10912F-dessert liking (derived food-liking factor)GCST900947540.01
10913F-coffee/alcohol liking (derived food-liking factor)GCST900947370.01
10914Overall health rating | General healthUKBB000006210.01
10915Tyrosine levels (UKB data field 23469)GCST902695660.01
10916Dermatophytosis / Dermatomycosis (PheCode 110)GCST904755600.01
10917RARRES2/ST6GAL1 ratioGCST903157590.01
10918GP2/LGALS4 ratioGCST903149600.01
10919Fluid intelligence score decline (log-difference score)GCST905658520.01
10920Pulmonary embolismGCST904681480.01
10921Platelet countGCST900024020.01
10922IDP dMRI TBSS ICVF Medial lemniscus RGCST900043350.01
10923IL12RB1 levelsGCST904695500.01
10924Sphingomyelin_33:1_[M+H]1+ levelsGCST900602290.01
10925SNAP23/SNAP29 ratioGCST903158550.01
10926C-reactive protein levels (UKB data field 30710)GCST904680640.01
10927Phlebitis and thrombophlebitis (PheCode 451)GCST904760030.01
10928Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)FING000010670.01
10929LAIR2 levelsGCST904697290.01
10930Total lipids in large LDLGCST904980110.01
10931Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T456ECGA0004560.01
10932Dermatophytosis (PheCode 110.1)GCST904755610.01
10933DCTPP1 levelsGCST904689610.01
10934Use of dietary supplements (confirmatory factor analysis Factor 13)GCST903093470.01
10935aparc-pial rh area postcentralGCST900031950.01
10936CLEC1B/DKK1 ratioGCST903140880.01
10937Left-hemisphere default mode network to right-hemisphere limbic network white-matter structural connectivityGCST903027640.01
10938X-03056--N-[3- 2-Oxopyrrolidin-1-yl propyl]acetamide levelsGCST902436190.01
10939Age at first birthGCST900000480.01
10940Physical activity (Total log acceleration 8pm-10pm)GCST900614190.01
10941BCR/ITGB1BP2 ratioGCST903134940.01
10942Squamous cell carcinoma (PheCode 172.22)GCST904755830.01
10943C9 levelsGCST904685050.01
10944Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T473ECGA0004730.01
10945Cardiorespiratory fitness slopeGCST900933190.01
10946Cod likingGCST900947360.01
10947CPB2 levelsGCST904688400.01
10948Ulcerative ileocolitisFING000013920.01
10949PI3 levelsGCST904702300.01
10950Type 1 diabetesGCST900005290.01
10951Exophthalmic conditionsFING000005260.01
10952EIF4B/MAP4K5 ratioGCST903146230.01
10953Frequency of solarium/sunlamp use | Sun exposureUKBB000002650.01
10954Prostate cancerGCST904281170.01
10955Pain type(s) experienced in last month - Stomach or abdominal pain | PainUKBB000006330.01
10956Hard cheese likingGCST900947780.01
10957DTI autoptx MD ilf r tractGCST903852350.01
10958Illnesses of siblings - None of the above (group 1) | Family historyUKBB000003530.01
10959Body mass indexGCST905029120.01
10960COPDFING000003500.01
10961Long-standing illness, disability or infirmity | General healthUKBB000004090.01
10962CCN2/EDAR ratioGCST903137110.01
10963BLVRB/HBQ1 ratioGCST903135250.01
10964DLL1/IL18BP ratioGCST903144950.01
10965Patient classification on admission (recoded) - Day case | Summary AdministrationUKBB000006360.01
10966SIGLEC6 levelsGCST904706340.01
10967CEP43/WASF1 ratioGCST903140230.01
10968Total free cholesterol levelsGCST900929880.01
10969Back pain (PheCode 760)GCST904762660.01
10970hemoglobin (mean, inv-norm transformed)GCST904753760.01
10971Other demyelinating diseases of the central nervous systemFING000009950.01
10972PLEKHO1 levelsGCST904702560.01
10973S100A11/SERPINB8 ratioGCST903157990.01
10974TNFRSF19 levelsGCST900889470.01
10975Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T443ECGU0004430.01
10976AmygNuclei rh volume Lateral-nucleusGCST900026580.01
10977LGALS8/TXNDC5 ratioGCST903153210.01
10978CD22 levelsGCST904686100.01
10979Number of sexual partners in opposite-sex sexual behaviorGCST900264800.01
10980Insulin fold change during an oral glucose tolerance testGCST902675680.01
10981Crohn's diseaseGCST904467930.01
10982HEPACAM2 levelsGCST904694450.01
10983aparc-a2009s lh area G-postcentralGCST900033240.01
10984Witnessed sudden violent death | Traumatic eventsUKBB000009170.01
10985Arthropathies in other diseases classified elsewhereFING000001080.01
10986Gallstone diseaseGCST901285180.01
10987mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed)GCST904754560.01
10988DNAJA2/SCAMP3 ratioGCST903145070.01
10989Cigarettes smoked per day (MTAG)GCST901791510.01
10990CLEC4D levelsGCST904687730.01
10991Verbal-numerical reasoningGCST0034980.01
10992SDC4/SELP ratioGCST903158170.01
10993IDP dMRI TBSS OD Genu of corpus callosumGCST900044040.01
10994Seborrheic dermatitis (PheCode 690.1)GCST904761710.01
10995HEXIM1/TRIAP1 ratioGCST903150540.01
10996Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)FING000007770.01
10997HypertensionGCST900860920.01
10998MSLN levelsGCST904699480.01
10999C-reactive protein | Blood biochemistryUKBB000001130.01
11000Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T483ECGA0004830.01